Catalyst Wire Dossier Catalyst Wire Dossier

REZDIFFRA

RESMETIROM · Madrigal Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for REZDIFFRA, covering 2024-03-14 to 2026-07-24. Get the full timeline:

Most recent: FDA Approved: REZDIFFRA — Supplemental Application (Madrigal Pharmaceuticals, Inc.)

See pricing